Laroche Richard F Jr - Apr 30, 2024 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ Richard F. LaRoche, Jr.
Stock symbol
NHC
Transactions as of
Apr 30, 2024
Transactions value $
$311,699
Form type
4
Date filed
5/1/2024, 04:40 PM
Previous filing
Dec 11, 2023
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock (held in my name or my wife's name) Options Exercise $312K +4K $77.92 0 Apr 30, 2024 Direct F1, F2
transaction NHC Common Stock (held in my name or my wife's name) Options Exercise $273K +3.5K $77.92 0 Apr 30, 2024 Direct F1, F2
transaction NHC Common Stock (held in my name or my wife's name) Tax liability -$273K -3K -1.47% $90.87 201K Apr 30, 2024 Direct F3, F4
holding NHC Common Stock (ROTH IRA) 115 Apr 30, 2024 Direct
holding NHC Common Stock - Family LP (BFLP) 30K Apr 30, 2024 GP
holding NHC Common Stock - Fam. Partnership (LR Ent.) 28K Apr 30, 2024 Direct
holding NHC Common Stock - Fam. Partnership (LFLP) 96K Apr 30, 2024 GP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock [2019 Grant] Options Exercise $0 -4K -53.33% $0.00 3.5K Apr 30, 2024 Common Stock 7.5K $77.92 Direct F1
transaction NHC Option to Purchase Common Stock [2019 Grant] Options Exercise $0 -3.5K -100% $0.00* 0 Apr 30, 2024 Common Stock 3.5K $77.92 Direct F1
holding NHC Option to Purchase Common Stock [2020 Grant] 5K Apr 30, 2024 Common Stock 5K $64.64 Direct
holding NHC Option to Purchase Common Stock [2021 Grant] 7.5K Apr 30, 2024 Common Stock 7.5K $71.64 Direct
holding NHC Option to Purchase Common Stock [2022 Grant] 7.5K Apr 30, 2024 Common Stock 7.5K $69.19 Direct
holding NHC Option to Purchase Common Stock [2023 Grant] 7.5K Apr 30, 2024 Common Stock 7.5K $55.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2019. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 Transaction totaled on the line below for securities of this title.
F3 Shares were withheld by the Company to pay the exercise price.
F4 Total amount for this title following transactions reported on this form.